Toothache
Drug research and approvals for toothache: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 17, 2026, 17 studies of toothache are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 17
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 17 recruiting on ClinicalTrials.gov ↗- Compare the Intensity of Pain Felt by Children During the Local Anesthesia Procedure to That Perceived by the…NCT07718477 · Not reported · University Hospital, Clermont-Ferrand · starts Oct 8, 2026
- A Study of CYT-1010 in Healthy Volunteers and Participants With Acute Pain After Third Molar ExtractionNCT07905105 · Phase 1 / Phase 2 · Cytogel Pharma, LLC · starts Sep 25, 2026
- Local Dexamethasone Administration in Symptomatic Irreversible PulpitisNCT07672873 · Not applicable · Marmara University · starts Jun 15, 2026
- Predicting Vital Pulp Treatment Outcomes in Symptomatic Pulpits Using Metabolic BiomarkerNCT07452614 · Not applicable · Abeer Ghalib Abdul-khaliq · starts Feb 20, 2026
- Preemptive Analgesia for Pain and Anxiety Control in Children With MIHNCT07374354 · Not applicable · October University for Modern Sciences and Arts · starts Feb 1, 2026
- An Emergency Department (ED) Provider Centered Intervention for Non-Traumatic Dental Condition Management (NTDC)NCT06330207 · Not applicable · University of Florida · starts Jan 15, 2026
- Neuropathic Dental Pain & DBSNCT07671950 · Not applicable · University of British Columbia · starts Jan 1, 2026
- Effectiveness of Aromatherapy and Digital Anesthesia in Managing Dental Anxiety and Pain in ChildrenNCT07547371 · Not applicable · Arzu Pınar Erdem · starts Dec 11, 2025
- Evaluation Of Laser Versus Conventional Pulpotomies In Mature Molar Teeth With Irreversible PulpitisNCT07287709 · Not applicable · Rana Hegaz · starts Nov 7, 2025
- Intraosseous vs Infiltration Anesthesia in Molar-Incisor Hypomineralization (MIH) ChildrenNCT07352813 · Not applicable · Ankara Yildirim Beyazıt University · starts Nov 7, 2025
Drug Pipeline
5 approved, 7 in phase 3, 9 in phase 2, 1 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this conditionApproved: Acetaminophen, Ibuprofen, Naproxen, Benzocaine, Aspirin
- Diclofenac
- Phase 3 Cyclooxygenase inhibitor
- Bupivacaine
- Phase 3 Sodium channel protein type IV alpha subunit blocker
- Codeine
- Phase 3 Opioid receptors; mu/kappa/delta agonist
- Tramadol
- Phase 3 Mu opioid receptor agonist
- Caffeine
- Phase 3 Adenosine receptor antagonist
- Etoricoxib
- Phase 3 Cyclooxygenase-2 inhibitor
- GW-406381
- Phase 3 Cyclooxygenase-2 inhibitor
- Celecoxib
- Phase 2 Cyclooxygenase-2 inhibitor
- Oxycodone
- Phase 2 Mu opioid receptor agonist
- ARRY-797
- Phase 2 MAP kinase p38 alpha inhibitor
- Buprenorphine
- Phase 2 Mu opioid receptor agonist
- Indomethacin
- Phase 2 Cyclooxygenase inhibitor
- Meloxicam
- Phase 2 Cyclooxygenase-2 inhibitor
- SB-705498
- Phase 2 Vanilloid receptor antagonist
- PF-05089771
- Phase 2 Sodium channel protein type IX alpha subunit blocker
- PF-04531083
- Phase 2 Sodium channel protein type X alpha subunit blocker
- Cannabidiol
- Phase 1 Cannabinoid CB1 receptor negative allosteric modulator
How Its Trials Ended
98 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 34 whose ending is known, 79% met their primary endpoint, 0% missed it and 21% stopped early.
- Completed, result not reported5556%
- Met its primary endpoint2728%
- Ongoing77%
- Stopped: other or unclear44%
- Stopped: enrollment or feasibility22%
- Status unknown22%
- Stopped: lack of efficacy11%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA